Unusual genetic variants associated with hypercholesterolemia in Argentina
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 277, 256-261
Abstract
No abstract availableKeywords
Funding Information
- Amgen Biotechnology Company
- University of Buenos Aires (20020170100259BA)
- Roemmers Foundation Argentina
- Boston Heart Diagnostics
This publication has 25 references indexed in Scilit:
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The history of Autosomal Recessive Hypercholesterolemia (ARH). From clinical observations to gene identificationGene, 2015
- LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemiasJournal of Lipid Research, 2014
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- ACMG clinical laboratory standards for next-generation sequencingGenetics in Medicine, 2013
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control studyThe Lancet, 2013
- Diagnosis and treatment of familial hypercholesterolaemiaEuropean Heart Journal, 2013
- Genetic analysis of familial hypercholesterolaemia in Western AustraliaAtherosclerosis, 2012
- Primary hypercholesterolemia: genetic causes and treatment of five monogenic disordersExpert Review of Cardiovascular Therapy, 2003
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988